Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study.

Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study.
复制标题

DOI:
10.1016/j.jad.2020.05.039
复制
发表时间:
2020-09
影响因子:
6.6
通讯作者:
S. Østergaard;M. Speed;C. Kellner;M. Mueller;S. McClintock;M. Husain;G. Petrides;W. McCall;S. Lisanby
S. Østergaard;M. Speed;C. Kellner;M. Mueller;S. McClintock;M. Husain;G. Petrides;W. McCall;S. Lisanby
中科院分区:
医学2区
文献类型:
--
作者:
S. Østergaard;M. Speed;C. Kellner;M. Mueller;S. McClintock;M. Husain;G. Petrides;W. McCall;S. Lisanby

文献摘要

被引文献

相似文献

背景电休克治疗(ECT)通常用于治疗重度抑郁症(MDD),但对中重度抑郁症可能同样有效。然而,这种可能性只在非常有限的范围内进行了研究。因此,我们调查ECT的疗效分层后,患者严重的抑郁症和中度严重的MDD.MethodsWe使用的数据,从延长缓解抑郁症的老年人(PRIDE)的研究,其中240例(≥60岁)与MDD的治疗与右侧单侧超短脉冲ECT,结合文拉法辛。我们使用汉密尔顿抑郁评定量表的六项核心抑郁子量表(HAM-D 6)来定义抑郁的严重程度。HAM-D 6总分≥12分为重度抑郁症,HAM-D 6总分<12分为中度抑郁症。结果重度抑郁症和中度抑郁症患者的HAM-D 6总分从基线到终点的平均变化为-8.2(95%置信区间(95%CI)= -7.5;-9.0,paired-test:p< 0.001)和-5.9(95%CI = -5.1;-6.6,paired-test:p< 0.001)。63%的重度抑郁症患者和75%的中度抑郁症患者达到缓解(HAM-D 6总分≤4)(Pearson双样本卡方检验组间差异:p= 0.27)。LimitationsThe PRIDE研究并非旨在解决此研究问题。扩大ECT的适应症以包括中度MDD患者可能是适当的。
BackgroundElectroconvulsive therapy (ECT) is usually reserved for treatment of severe major depressive disorder (MDD), but may be equally effective in the treatment of moderate-severity MDD. This possibility, however, has only been studied to a very limited extent. We therefore investigated the efficacy of ECT after stratifying patients into severe MDD and moderate-severity MDD.MethodsWe used data from the Prolonging Remission in Depressed Elderly (PRIDE) study, in which 240 patients (≥60 years) with MDD were treated with right unilateral ultrabrief pulse ECT, combined with venlafaxine. We used the six-item core depression subscale (HAM-D6) of the Hamilton Depression Rating Scale to define depression severity. Participants with baseline total scores ≥12 on the HAM-D6were considered to have severe MDD, while those with HAM-D6total scores <12 were considered to have moderate-severity MDD.ResultsAmong the participants with severe MDD and moderate-severity MDD, the mean change in the HAM-D6total score from baseline to endpoint was -8.2 (95% confidence interval (95%CI) = -7.5; -9.0, pairedt-test:p< 0.001) and -5.9 (95%CI = -5.1; -6.6, pairedt-test:p< 0.001), respectively. A total of 63% of those with severe MDD and 75% of those with moderate-severity MDD achieved remission (HAM-D6total score ≤4) (Pearson's 2-sample chi-squared test of difference between groups:p= 0.27).LimitationsThe PRIDE study was not designed to address this research question.ConclusionsECT combined with venlafaxine appears to be an effective treatment for moderate-severity MDD. It may be appropriate to expand the indications for ECT to include patients with moderate-severity MDD.